InnovAge (INNV) Competitors $4.08 -0.32 (-7.27%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends INNV vs. ARDT, ADUS, PACS, WGS, NHC, TDOC, FTRE, VRDN, AHCO, and CDNAShould you be buying InnovAge stock or one of its competitors? The main competitors of InnovAge include Ardent Health Partners (ARDT), Addus HomeCare (ADUS), PACS Group (PACS), GeneDx (WGS), National HealthCare (NHC), Teladoc Health (TDOC), Fortrea (FTRE), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), and CareDx (CDNA). These companies are all part of the "healthcare" industry. InnovAge vs. Ardent Health Partners Addus HomeCare PACS Group GeneDx National HealthCare Teladoc Health Fortrea Viridian Therapeutics AdaptHealth CareDx Ardent Health Partners (NYSE:ARDT) and InnovAge (NASDAQ:INNV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Is ARDT or INNV more profitable? Ardent Health Partners has a net margin of 0.00% compared to InnovAge's net margin of -2.03%. Ardent Health Partners' return on equity of 0.00% beat InnovAge's return on equity.Company Net Margins Return on Equity Return on Assets Ardent Health PartnersN/A N/A N/A InnovAge -2.03%-5.68%-2.99% Which has preferable earnings and valuation, ARDT or INNV? Ardent Health Partners has higher revenue and earnings than InnovAge. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArdent Health Partners$5.71B0.42$53.90MN/AN/AInnovAge$786.51M0.70-$21.34M-$0.12-34.00 Does the MarketBeat Community favor ARDT or INNV? Ardent Health Partners received 15 more outperform votes than InnovAge when rated by MarketBeat users. Likewise, 83.33% of users gave Ardent Health Partners an outperform vote while only 0.00% of users gave InnovAge an outperform vote. CompanyUnderperformOutperformArdent Health PartnersOutperform Votes1583.33% Underperform Votes316.67%InnovAgeOutperform VotesNo VotesUnderperform Votes5100.00% Does the media favor ARDT or INNV? In the previous week, Ardent Health Partners had 2 more articles in the media than InnovAge. MarketBeat recorded 6 mentions for Ardent Health Partners and 4 mentions for InnovAge. Ardent Health Partners' average media sentiment score of 1.43 beat InnovAge's score of 0.86 indicating that Ardent Health Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health Partners 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in ARDT or INNV? 12.3% of InnovAge shares are held by institutional investors. 1.4% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate ARDT or INNV? Ardent Health Partners currently has a consensus target price of $22.00, indicating a potential upside of 31.26%. InnovAge has a consensus target price of $6.00, indicating a potential upside of 47.06%. Given InnovAge's higher possible upside, analysts clearly believe InnovAge is more favorable than Ardent Health Partners.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ardent Health Partners 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00InnovAge 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 SummaryArdent Health Partners beats InnovAge on 12 of the 16 factors compared between the two stocks. Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Get InnovAge News Delivered to You Automatically Sign up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INNV vs. The Competition Export to ExcelMetricInnovAgeHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$552.66M$930.44M$5.18B$9.30BDividend YieldN/A1.87%4.78%4.06%P/E Ratio-34.0037.27132.5417.55Price / Sales0.704.181,260.41139.00Price / CashN/A25.0440.9437.95Price / Book2.002.994.894.91Net Income-$21.34M-$3.80M$119.18M$225.69M7 Day Performance-15.53%-6.72%14.55%-1.47%1 Month Performance-22.43%-1.62%17.43%5.37%1 Year Performance-28.30%280.20%35.26%22.71% InnovAge Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INNVInnovAge1.4494 of 5 stars$4.08-7.3%$6.00+47.1%-28.3%$552.66M$786.51M-34.002,350Analyst ForecastNews CoveragePositive NewsHigh Trading VolumeARDTArdent Health PartnersN/A$16.79+0.6%$21.82+29.9%N/A$2.40B$5.71B0.0024,200Analyst ForecastNews CoveragePositive NewsADUSAddus HomeCare4.7566 of 5 stars$129.54+3.6%$133.67+3.2%+40.9%$2.35B$1.06B28.6034,846Analyst ForecastShort Interest ↓PACSPACS Group3.7481 of 5 stars$15.32-0.6%$39.88+160.3%N/A$2.33B$3.11B0.0032,433Analyst ForecastWGSGeneDx1.496 of 5 stars$78.37+3.9%$59.33-24.3%+3,159.3%$2.15B$267.23M-24.251,200NHCNational HealthCareN/A$122.36+0.8%N/AN/A$1.89B$1.23B15.2213,123TDOCTeladoc Health2.4882 of 5 stars$10.77+3.4%$12.24+13.6%-50.9%$1.85B$2.60B-1.815,600FTREFortrea2.2356 of 5 stars$19.99-0.1%$23.30+16.6%-39.0%$1.79B$3.11B-5.8518,000VRDNViridian Therapeutics2.9361 of 5 stars$21.98+23.1%$36.33+65.3%+8.3%$1.74B$310,000.00-5.2950Analyst ForecastNews CoverageGap UpHigh Trading VolumeAHCOAdaptHealth3.0107 of 5 stars$9.99+4.6%$11.67+16.8%+29.7%$1.34B$3.26B-5.7910,700CDNACareDx3.7729 of 5 stars$22.61-1.1%$29.60+30.9%+122.1%$1.21B$280.32M-8.35740Short Interest ↑ Related Companies and Tools Related Companies ARDT Competitors ADUS Competitors PACS Competitors WGS Competitors NHC Competitors TDOC Competitors FTRE Competitors VRDN Competitors AHCO Competitors CDNA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INNV) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
